Quantcast
Menu
Save, make, understand money

Investing

Results round-up: Companies to watch this week

Lucinda Beeman
Written By:
Lucinda Beeman
Posted:
Updated:
28/07/2014

It’s a rip-roaring week for the markets as many major companies prepare to report their results to investors.

Monday 28 July

Aberdeen Asset Management – third quarter results

Everything Everywhere – second quarter results

National Grid – interim management statement

No major drama is expected from National Grid this time around, though investors will hoping for confirmation that trading is in line with expectations. Investors should listen out for any announcements to do with the group’s US operations.

Reckitt Benckiser – second quarter results

Ryanair Holdings – first quarter results

Tuesday 29 July

BP – second quarter results

Investors will be hoping results have kept pace with the first quarter’s encouraging numbers. The unrest in Ukraine and Russia has lifted energy prices, which should help with average oil prices, but the group’s part ownership of Russian oil company Rosneft could mean problems down the line if sanctions come through. Investors should be paying attention to management’s thoughts on the matter.

GKN – second quarter results

Hutchison China MediTech – second quarter results

Next Plc – second quarter trading statement

St James’s Place – Interim management statement

This group has been going from strength to strength lately and investors will be hoping for more of the same. Areas to note include expansion into Asia and any early signs of benefits from George Osborne’s ISA and pension reform.

Wednesday 30 July

Antofagasta – second quarter results

Barclays – second quarter results

British American Tobacco – second quarter results

Compass – second quarter management statement

ITV – second quarter results

National Express Group – second quarter results

Peugeot-Citreon – first half results

Rightmove plc – interim results

Shire – second quarter results

Tullow Oil – second quarter results

Vendata Resources – first quarter results

Thursday 31 July

AstraZeneca – second quarter results

Fellow pharmaceutical company GlaxoSmithKline disappointed the markets this week and next up is AstraZeneca. Likely competition from generic drugs will hurt revenues, though the rejection of Pfizer’s takeover approach earlier this year means that investors will want to see convincing evidence that Astra can make it alone when it comes to research and development. Cost cutting programs will also be of interest.

BAE Systems – second quarter results

BG Group – second quarter results

BNP Paribas – interim results

BT – first quarter results

Centrica – second quarter results

Diageo – fourth quarter results

Rolls Royce – second quarter results

Rolls Royce already warned customers not to expect sales growth this year, but investors will be hoping management is more optimistic for 2015. The future of the defence industry may be brighter – budget cuts have hurt Rollys Royce but the worst may be over. The key will be the company’s participation in the civil aerospace industry, where it is performing well. Investors will be looking out for the size of the order backlog and the mix between original equipment and after sales contracts.

Royal Dutch Shell – second quarter results

Thomas Cook Group plc – third quarter interim management statement

TSB Bank plc – interim results

Weir Group – second quarter results

Friday 1 August

IMI – second quarter results

With a new CEO on board, IMI is undergoing a strategic review. Currency and its impact on profits may be making investors in the company nervous, as will potential pressure on margins. The group was forecasting an improvement in the second half of the year, so an update and confirmation of this good news will be important to investors.

International Consolidated Airlines – second quarter results

ISM – report on business, manufacturing

Rexam – second quarter results

Royal Bank of Scotland – second quarter results

Smith & Nephew – second quarter results

The last couple of years have been exceptional for Smith & Nephew and growth targets have left it an attractive acquisition target. Nothing has materialised thus far – despite some interest from US firms – and investors will be looking for management’s thoughts.

William Hill – second quarter results

Source: The Share Centre, Headline Money